PATENT CLAIM ANALYSIS

Application Number: 15876462
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["546", "118000"]

Abstract:
The present invention provides pyridinonyl PDK1 inhibitors and methods of treating cancer using the same.

Claim (Index 50):
A method for selectively reducing PDK1-mediated phosphorylation of Akt relative to PDK1-mediated phosphorylation of PKC in a cell, the method comprising:\n contacting the cell with an effective amount of a compound of  claim 47 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14328256', '12307104', '11733758', '14966821', '12567258']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8018834702407679
- 35 USC 102 Novelty (BERT): 0.5363956696222848
- Combined Prediction Score: 0.7753346901789196
- Mean Citation Score: 341.392426
- Max Citation Score: 393.86432
- Similarity Product: 305.8215300594712

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test